BPC-157 is not intended for human or veterinary administration
A., da Silva, J
A licensed healthcare provider will review medical history, goals, and eligibility before making recommendations
Your provider monitors your response with follow-up testing, not just a phone call
Some portion of intranasally administered peptides may reach the brain through the olfactory pathway, bypassing the blood-brain barrier that limits systemic delivery to CNS tissues
Zepbound may cause other serious side effects, including severe gastrointestinal disease, kidney injury, gallbladder disease, inflammation of the pancreas, severe allergic reactions, low blood sugar, complications in patients with diabetic retinopathy, and suicidal thoughts